These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7459947)
21. [Hodgkin disease treated at the Tromsø regional hospital 1985-93. Diagnosis, treatment, prognosis, quality of life and costs of a decentralized treatment]. Norum J; Wist E Tidsskr Nor Laegeforen; 1997 Jan; 117(1):23-6. PubMed ID: 9064805 [TBL] [Abstract][Full Text] [Related]
22. [Clinical features and combined treatment of the central nervous system in Hodgkin's disease]. Filatova LV; Gershanovich ML Vopr Onkol; 2008; 54(5):643-52. PubMed ID: 19069483 [TBL] [Abstract][Full Text] [Related]
23. Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy. Czyz J; Szydlo R; Knopinska-Posluszny W; Hellmann A; Gozdzik J; Hansz J; Smolewski P; Robak T; Osowiecki M; Walewski J; Avigdor A; Nagler A; Zemelka T; Pawlicki M; Sawicki Z; Wojtukiewicz M; Kachel L; Holowiecki J; Charlinski G; Jedrzejczak WW Bone Marrow Transplant; 2004 Jun; 33(12):1225-9. PubMed ID: 15094747 [TBL] [Abstract][Full Text] [Related]
25. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor. Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922 [TBL] [Abstract][Full Text] [Related]
26. [Simultaneous occurrence of breast carcinoma and malignant lymphoma. Case observations and literature review]. Frey BM; Morant R; Senn HJ; Fisch T; Schmid U Schweiz Med Wochenschr; 1994 Jun; 124(23):1010-6. PubMed ID: 8023099 [TBL] [Abstract][Full Text] [Related]
31. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Urquhart A; Berg R Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605 [TBL] [Abstract][Full Text] [Related]
35. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091 [TBL] [Abstract][Full Text] [Related]
36. [Contribution to the study of the osseous localiza tions of malignant lymphogranuloma]. Franco L; Anfossi F; Rossi PL Minerva Radiol; 1966 Nov; 11(11):551-8. PubMed ID: 5996290 [No Abstract] [Full Text] [Related]
38. Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group. Klimm B; Reineke T; Haverkamp H; Behringer K; Eich HT; Josting A; Pfistner B; Diehl V; Engert A; J Clin Oncol; 2005 Nov; 23(31):8003-11. PubMed ID: 16204002 [TBL] [Abstract][Full Text] [Related]
39. Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV. Doerler M; Hyun J; Venten I; Potthoff A; Bartke U; Serova K; Hoextermann S; Altmeyer P; Brockmeyer NH Eur J Med Res; 2007 Oct; 12(10):497-502. PubMed ID: 18024256 [TBL] [Abstract][Full Text] [Related]
40. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials. Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]